The global animal health sector is experiencing significant shifts driven by long-acting biopharmaceuticals, evolving distribution channels, and persistent biosecurity challenges. Industry projections see the...
Boehringer Ingelheim is preparing to relocate its Australia and New Zealand headquarters to MPark at 15 Khartoum Road, Macquarie Park, Sydney, Australia, while maintaining...
Janus Kinase (JAK) Inhibitors represent one of the most commercially lucrative and clinically transformative therapeutic classes in modern companion animal health. Used primarily in...
A groundbreaking agricultural innovation is emerging from Galicia, northwestern Spain, where the Alganut project is developing seaweed-based animal feed enriched with selenium to simultaneously...
Xeptiva develops therapeutic vaccines for chronic pet diseases
Uruguayan biotechnology company Xeptiva Therapeutics is developing a portfolio of therapeutic vaccines designed to address chronic inflammatory...
Zomedica has entered a strategic partnership with Veterinary Management Groups (VMG) to make its diagnostic, therapeutic and remote-monitoring technologies available on preferred terms to...
Zoetis has expanded the capabilities of its Vetscan Imagyst AI blood-smear application, adding detection of important blood parasites including microfilariae and Babesia spp. in...
Endovia Health Sciences has closed an initial $500,000 tranche of a previously announced $1 million financing commitment to advance CannEpil®, its cannabinoid-based pharmaceutical candidate,...
Precision-medicine company ImpriMed has secured a $10 million Series A2 bridge round, with NAVER D2SF participating, as the company expands its AI-driven drug-response platform...
Los Angeles-based NanosVet has raised $8.3 million in an SEC-reported securities offering, providing fresh capital to expand its fast-dissolving oral-film platform from pet wellness...
